AI assistant
SCI Interim / Quarterly Report 2016
52383_rns_2016-10-21_6ab1fd3e-e0ff-417e-afd5-dbf307184c42.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
員工數Employee:235 設立日期:中華民國七十六年九月十八日 Date of establishment: Sep. 18, 1987 資本額Capital:新台幣795佰萬元(NTD 795mn) 營業項目Business: 原料藥API(62.64%) 中間體Intermediate(31.98%) 特用化學品 Custom-made chemicals(5.38%)
公司概況Outline
| Y2015 | Jan-Sep.,2016 | |
|---|---|---|
| 歐 洲Europe |
37.07% | 36.81% |
| 美 洲America |
28.81% | 39.19% |
| 亞 洲Asia |
21.17% | 10.78% |
| 內Taiwan 國 |
9.44% | 10.47% |
| 他 others 其 |
3.51% | 2.75% |
| 計Total 合 |
100.00% | 100.00% |
Unit: K NTD
| 2016 Q1~Q2 | 2016 Q3 | |
|---|---|---|
| 營收Sales | 1,168,084 | 476,679 |
| 營業成本COGS | (650,270) | (287,870) |
| 毛利Gross Profit | 517,814 | 188,809 |
| 毛利率 GP Ratio | 44.3% | 39.6% |
| 營業費用Operating Expenses | (158,130) | (63,518) |
| 營業利益Operating Income | 359,684 | 125,291 |
| 營業外損益Non-Operating In/Ex | (8,192) | (11,550) |
| 稅前淨利 Net Profit before Tax | 351,492 | 113,741 |
| 所得稅Income Tax | (63,078) | |
| 本期淨利Net Profit after Tax | 288,414 |
產品組合-Products
| Y2013 | % | Y2014 | % | Y2015 | % |
|---|---|---|---|---|---|
| PGA | 18.31% | PGA | 17.49% | HOCLQ | 21.52% |
| Di-VANa | 16.92% | Di-VANa | 10.09% | PGA | 17.14% |
| S20/38 | 8.39% | LPF.Na | 8.74% | V.A. | 10.64% |
| V.A. | 8.23% | S20/38 | 8.25% | LPF.Na | 7.48% |
| LPF.Na | 6.58% | V.A. | 8.15% | Di-VaNa | 5.41% |
| PPON | 6.53% | DBS | 4.60% | S20/38 | 4.01% |
| 5-HMT | 4.51% | 5-HMT | 4.12% | 5-HMT | 3.08% |
| PEB.Na | 3.98% | NaVA | 3.65% | DBS | 2.98% |
| NaVa | 3.34% | Pent-2 | 3.64% | Pent-2 | 2.68% |
| DBS | 2.63% | M115 | 3.33% | Dulox | 2.61% |
| Total | 79.42% | Total | 72.06% | Total | 77.55% |
| Product | % | Jan~Sep, 2016Sales (NT\$) |
|---|---|---|
| HOCLQ Sulfate | 33.48 | 550,627,794 |
| PGA | 15.12 | 248,747,073 |
| VA Series | 13.77 | 226,500,380 |
| Pent-2 / PEB.Na | 6.84 | 112,638,265 |
| S-MMAA / Dulo | 5.75 | 94,549,974 |
| 5-HMT / wing | 5.53 | 90,959,211 |
| LPF.Na | 3.64 | 59,816,222 |
| PPON | 1.93 | 31,673,519 |
Hydroxychloroquine sulfate
風濕性關節炎藥物 For rheumatoid arthritis treatment
Unit : K NT\$
Pyrogallolaldehyde ( PGA) - Benserazide
Unit : K NT\$
產品介紹Product
VA series-
Unit : K NT\$
Valproic Acid, Divalproex Sodium, Sodium Valproate
治療癲癇藥物 For epilepsy treatment Di-Va學名藥於2009推出 Di-Va generic came out in 2009
產品介紹Product
Loxoprofen sodium Unit : K NT\$
抗發炎藥物 Anti-inflammatory 日本市場200-300公噸 Japan market:200-300MT 2015: 25T(噸)
S20/38
臨床藥物 Medication in clinical trial
5-HMT/Wing
Unit : K NT\$
愛滋病藥物中間體 For AIDS treatment Intermediates for Ritonavir and Lopinavir
產品介紹Product
Pent-2/Pentobarbital Sodium
Unit : K NT\$
鎮定安眠用中間體及原料藥 Intermediate and API for calmative
S-MMAA/Duloxetine
Unit : K NT\$
抗憂鬱症藥物 Antidepressant 2013年底Duloxetine專利到期 Duloxetine's patent expired in the end of 2013
GMP Status(GMP現況)
| API | CGMP Certified (TFDA) |
CEP (EDQM) |
DMF (USA) |
MF (Japan) |
DMF (Canada) |
|---|---|---|---|---|---|
| Valproic Acid (*) (#) | 2003 | 2004 | 2003 | 2008 | 2008 |
| Allopurinol | 2004 | 2003 | 2011 | ||
| Sodium Valproate |
2004 | 2006 | |||
| Divalproex Sodium (**)(#) |
2005 | 2005 | 2010 | ||
| Bisoprolol Fumarate |
2006 | ||||
| Pentobarbital Sodium |
2009 | 2 011 |
|||
| Propafenone Hydrochloride |
2010 | 2012 | 2010 | 2012 | 2012 |
| Methylphenidate HCl |
2 011 |
2014 | |||
| Duloxetine Hydrochloride |
2012 | 2014 | 2010/2011 | ||
| Thiopental | 2012 | ||||
| Loxoprofen Sodium Hydrate |
2012 | 2011 | |||
| Articaine Hydrochloride |
2013 | 2014 | 2014 | ||
| Hydroxychloroquine Sulfate(#) |
2014 | 2014 | 2014 | ||
| Clindamycin Palmitate HCl |
2011 | ||||
| Cyclophosphamide | 2014 | 2012 | |||
| Brinzolamide | 2015 | 2015 | |||
| Probucol | 2015 | 2004 |
(*)(**) FDA inspection: Nov. 2005 / April 2012, (*) EDQM inspection: Nov. 2010, (#) FDA inspection: Dec. 2014.
